Granules India increased 2.04% to Rs 581.15 after it disclosed that it had received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for its API Unit-I facility in Bonthapally, Hyderabad...
Alembic Pharmaceuticals Limited (Alembic) declares that it has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ticagrelor Tablets, 60 mg.
The fifth edition of the Pink Mela - a unique and vibrant event dedicated to raising awareness about breast cancer, brought together entertainment and education for women in Nashik. Organized jointly by HCG Manavata Cancer Centre (HCGMCC) and...
Max Healthcare, India’s one of the most populous hospital chains by revenue, will be funded entirely through internal accruals. Free cash flow of the company will be enough to support the expansion without raising debt
.png "Akums Begins Building Its First Overseas Plant in Zambia")
Akums Drugs & Pharmaceuticals Ltd. has commenced the construction of its first global manufacturing facility in Zambia, representing a significant advancement in its international expansion efforts. The ceremonial groundbreaking was initiated...
Swiss pharmaceutical company Novartis achieved its profit forecast for the third quarter on Tuesday, as robust growth from newer medications compensated for a significant decline in sales of its leading heart medication, Entresto, which is facing com
Philips has revealed an enhancement of its partnership with Nicolab, a prominent AI-based stroke management company, to improve stroke diagnosis and treatment in India. This partnership signifies a noteworthy step towards addressing one...
Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel therapies that address emerging targets in oncology, is presenting preclinical data on RVU305
.jpeg "CDSCO Launches ONDLS to Track High-Risk Pharma Solvents")
After the discovery of diethylene glycol (DEG) in some cough syrups, the Central Drugs Standard Control Organisation (CDSCO) has launched a digitally monitored system on the Online National Drug Licensing System (ONDLS) portal.
IOL Chemicals & Pharmaceuticals Limited (IOLCP) is proud to announce an important milestone in their pharmaceutical division after being awarded a Certificate of Suitability
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")